CLINICAL STUDIES
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension
A therapeutic alternative for patients nonresponsive to vasodilator treatment
Julio Sandoval, MD, FACCa,
Jorge Gaspar, MD, FACCa,
Tomás Pulido, MDa,
Edgar Bautista, MDa,
Maria Luisa Martínez-Guerra, MDa,
Marco Zeballos, MDa,
Andrés Palomar, MDa and
Arturo Gómez, MDa
a Cardiopulmonary and the Interventional Catheterization Laboratory Departments, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
Manuscript received January 13, 1998;
revised manuscript received April 16, 1998,
accepted April 27, 1998.
Address for correspondence: Dr. Julio Sandoval, Cardiopulmonary Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1, Tlalpan 14080, Mexico D.F., Mexico sandoval{at}compuserve.com.mx
Objectives. We sought to investigate the acute hemodynamic effects of graded balloon dilation atrial septostomy (BDAS) and to define the long-term impact of this procedure on New York Heart Association functional class and survival in adult patients with primary pulmonary hypertension (PPH).
Background. Current treatment strategies for patients with severe and refractory PPH are limited by either technical difficulties and high mortality or cost.
Methods. We studied 15 patients with severe PPH. BDAS was successfully performed in all patients by crossing the interatrial septum with a Brockenbrough needle, followed by progressive dilation of the orifice with a Mansfield balloon in a hemodynamically controlled, step-by-step manner.
Results. BDAS caused an immediate significant fall in right ventricular end-diastolic pressure and in systemic arterial oxygen saturation and an increase in cardiac index. One patient died, and 14 survived the procedure and significantly improved their mean functional class (from 3.57 ± 0.6 to 2.07 ± 0.3 [mean ± SD], p < 0.001). Exercise endurance (6-min test) also improved from 107 ± 127 to 217 ± 108 m (p < 0.001). Because of spontaneous closure, BDAS was repeated in four patients. The survival rate among patients who survived the procedure was 92% at 1, 2 and 3 years, which is better than that for historical control PPH patients (73%, 59% and 52%, respectively).
Conclusions. With careful monitoring, BDAS is a safe and useful palliative treatment for selected patients with severe PPH.
|
Abbreviations and Acronyms
| | BBAS | = blade-balloon atrial septostomy | | BDAS | = balloon dilation atrial septostomy | | CI | = cardiac index | | LVEDP | = left ventricular end-diastolic pressure | | PAP | = pulmonary artery pressure | | PPH | = primary pulmonary hypertension | | PVRI | = pulmonary vascular resistance index | | RAP | = right atrial pressure | | RVEDP | = right ventricular end-diastolic pressure | | SaO2% | = systemic arterial oxygen saturation |
|
This article has been cited by other articles:

|
 |

|
 |
 
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J.,
October 2, 2009;
30(20):
2493 - 2537.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Keogh, E. Mayer, R. L. Benza, P. Corris, P. G. Dartevelle, A. E. Frost, N. H. Kim, I. M. Lang, J. Pepke-Zaba, and J. Sandoval
Interventional and surgical modalities of treatment in pulmonary hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S67 - S77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Barst, J. S. R. Gibbs, H. A. Ghofrani, M. M. Hoeper, V. V. McLaughlin, L. J. Rubin, O. Sitbon, V. F. Tapson, and N. Galie
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S78 - S84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
J. Am. Coll. Cardiol.,
April 28, 2009;
53(17):
1573 - 1619.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Circulation,
April 28, 2009;
119(16):
2250 - 2294.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. McGoon and G. C. Kane
Pulmonary Hypertension: Diagnosis and Management
Mayo Clin. Proc.,
February 1, 2009;
84(2):
191 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Boutet, D. Montani, X. Jais, A. Yaici, O. Sitbon, G. Simonneau, and M. Humbert
Review: Therapeutic advances in pulmonary arterial hypertension
Therapeutic Advances in Respiratory Disease,
August 1, 2008;
2(4):
249 - 265.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt
Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure
Circulation,
April 1, 2008;
117(13):
1717 - 1731.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Heart,
March 1, 2008;
94(Suppl_1):
i1 - i41.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Thorax,
March 1, 2008;
63(Suppl_2):
ii1 - ii41.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kurzyna and A. Torbicki
Neurohormonal modulation in right ventricular failure
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H35 - H40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ciarka, J.-L. Vachiery, A. Houssiere, M. Gujic, E. Stoupel, S. Velez-Roa, R. Naeije, and P. van de Borne
Atrial Septostomy Decreases Sympathetic Overactivity in Pulmonary Arterial Hypertension
Chest,
June 1, 2007;
131(6):
1831 - 1837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Tapson
Atrial Septostomy: Why We Still Need It
Chest,
April 1, 2007;
131(4):
947 - 948.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kurzyna, M. Dabrowski, D. Bielecki, A. Fijalkowska, P. Pruszczyk, G. Opolski, J. Burakowski, M. Florczyk, W. Z. Tomkowski, L. Wawrzynska, et al.
Atrial Septostomy in Treatment of End-Stage Right Heart Failure in Patients With Pulmonary Hypertension
Chest,
April 1, 2007;
131(4):
977 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D J Fox and R S Khattar
Pulmonary arterial hypertension: classification, diagnosis and contemporary management
Postgrad. Med. J.,
November 1, 2006;
82(973):
717 - 722.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. McLaughlin and M. D. McGoon
Pulmonary Arterial Hypertension
Circulation,
September 26, 2006;
114(13):
1417 - 1431.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Micheletti, A A Hislop, A Lammers, P Bonhoeffer, G Derrick, P Rees, and S G Haworth
Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension
Heart,
July 1, 2006;
92(7):
969 - 972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Rubin
Pulmonary arterial hypertension.
Proceedings of the ATS,
January 1, 2006;
3(1):
111 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Rubin and D. B. Badesch
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Ann Intern Med,
August 16, 2005;
143(4):
282 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Rashid and D Ivy
Severe paediatric pulmonary hypertension: new management strategies
Arch. Dis. Child.,
January 1, 2005;
90(1):
92 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al.
Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
Eur. Heart J.,
December 2, 2004;
25(24):
2243 - 2278.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert, O. Sitbon, and G. Simonneau
Treatment of Pulmonary Arterial Hypertension
N. Engl. J. Med.,
September 30, 2004;
351(14):
1425 - 1436.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Doyle, D. McCrory, R. N. Channick, G. Simonneau, and J. Conte
Surgical Treatments/Interventions for Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
July 1, 2004;
126(1_suppl):
63S - 71S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Klepetko, E. Mayer, J. Sandoval, E. P. Trulock, J.-L. Vachiery, P. Dartevelle, J. Pepke-Zaba, S. W. Jamieson, I. Lang, and P. Corris
Interventional and surgical modalities of treatment for pulmonary arterial hypertension
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12_Suppl_S):
73S - 80S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Galie, W. Seeger, R. Naeije, G. Simonneau, and L. J. Rubin
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12_Suppl_S):
81S - 88S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R J Allcock, J J O'Sullivan, and P A Corris
Atrial septostomy for pulmonary arterial hypertension
Heart,
November 1, 2003;
89(11):
1344 - 1347.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Reichenberger, J Pepke-Zaba, K McNeil, J Parameshwar, and L M Shapiro
Atrial septostomy in the treatment of severe pulmonary arterial hypertension
Thorax,
September 1, 2003;
58(9):
797 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert, O. Sitbon, and G. Simonneau
Novel therapeutic perspectives in pulmonary arterial hypertension
Eur. Respir. J.,
August 1, 2003;
22(2):
193 - 194.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Widlitz and R.J. Barst
Pulmonary arterial hypertension in children
Eur. Respir. J.,
January 1, 2003;
21(1):
155 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Galie, A. Manes, and A. Branzi
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
Eur. Respir. J.,
October 1, 2002;
20(4):
1037 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schulz, G. Baseler, H.A. Ghofrani, F. Grimminger, H. Olschewski, and W. Seeger
Nocturnal periodic breathing in primary pulmonary hypertension
Eur. Respir. J.,
April 1, 2002;
19(4):
658 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bossone, G. Paciocco, D. Iarussi, A. Agretto, A. Iacono, B. W. Gillespie, and M. Rubenfire
The Prognostic Role of the ECG in Primary Pulmonary Hypertension
Chest,
February 1, 2002;
121(2):
513 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. HOEPER, N. GALIE, S. MURALI, H. OLSCHEWSKI, M. RUBENFIRE, I. M. ROBBINS, H. W. FARBER, V. MCLAUGHLIN, S. SHAPIRO, J. PEPKE-ZABA, et al.
Outcome after Cardiopulmonary Resuscitation in Patients with Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
February 1, 2002;
165(3):
341 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Mendeloff, B. F. Meyers, T. M. Sundt, T. J. Guthrie, S. C. Sweet, M. de la Morena, S. Shapiro, D. T. Balzer, E. P. Trulock, J. P. Lynch, et al.
Lung transplantation for pulmonary vascular disease
Ann. Thorac. Surg.,
January 1, 2002;
73(1):
209 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
British Cardiac Society Guidelines and Medical Pra
Recommendations on the management of pulmonary hypertension in clinical practice
Heart,
September 1, 2001;
86(90001):
i1 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Galiè and A. Torbicki
GENERAL CARDIOLOGY: Pulmonary arterial hypertension: new ideas and perspectives
Heart,
April 1, 2001;
85(4):
475 - 480.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Menzel, S. Wagner, T. Kramm, S. Mohr-Kahaly, E. Mayer, S. Braeuninger, and J. Meyer
Pathophysiology of Impaired Right and Left Ventricular Function in Chronic Embolic Pulmonary Hypertension : Changes After Pulmonary Thromboendarterectomy
Chest,
October 1, 2000;
118(4):
897 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.M Weiss and O.M Hess
Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives
Eur. Heart J.,
January 2, 2000;
21(2):
104 - 115.
[PDF]
|
 |
|

|
 |

|
 |
 
Atrial Septostomy for Severe Primary Pulmonary Hypertension
Journal Watch Cardiology,
August 21, 1998;
1998(821):
9 - 9.
[Full Text]
|
 |
|
|